Skip to main content
Premium Trial:

Request an Annual Quote

Strand Gets Investment from Burrill

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

The amount of Burrill's investment is not being disclosed by the Bangalore, India-based bioinformatics firm. However, Strand noted that the financing included both a primary investment into the firm and a secondary buy-out of the lead investors from its Series A round.

Strand said that it will use the funds to accelerate its growth in the diagnostics market and expand its global reach. In particular, it cited its efforts to apply next-generation sequencing data to screening and identification of diseases and personalized medicine.

Though known primarily for its bioinformatics offerings, last year Strand inked a licensing deal to offer Trovagene's human papillomavirus urine test and high-risk HPV DNA assay in India and countries in the South Asian Association for Regional Cooperation for clinical diagnostic and carrier screening applications.

"Strand is strongly positioned to play a pivotal role in the transformation of healthcare due to the convergence of information technology and life sciences," David Wetherell, president and COO of Burrill Healthcare Venture and Private Equity Funds, said in a statement.

Burrill was the sole investor in the Series B round.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.